Michael Myers, Chief Executive Officer at Quoin Pharmaceuticals, Ltd. (QNRX), bought 1,111,112 shares at $0.45 ($500K) on 2024-12-23, disclosed to the SEC on 2024-12-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 555,556 | $250K | 50.0% |
| 2 | $0.45 | 555,556 | $250K | 50.0% |
| Total | $0.45 avg | 1,111,112 | $500K | 100% |
| Filing → |
| INPH | BUY | 2012-05-23 | $29K | — | Filing → |
| INPH | SELL | 2012-04-20 | $62K | — | Filing → |
| INPH | SELL | 2012-04-17 | $52K | — | Filing → |